Kallo Inc. (KALO)
- Previous Close
0.0003 - Open
0.0003 - Bid --
- Ask --
- Day's Range
0.0003 - 0.0003 - 52 Week Range
0.0003 - 0.0003 - Volume
41 - Avg. Volume
0 - Market Cap (intraday)
1.907M - Beta (5Y Monthly) 2.62
- PE Ratio (TTM)
0.03 - EPS (TTM)
0.0100 - Earnings Date --
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
--
Kallo Inc., together with its subsidiaries, focuses on developing medical information technology software. The company's products in development include Electronic Medical Records (EMR) Integration Engine, a software, which connects various other applications in or outside a hospital/clinic with the EMR system; Communicable and Infectious Disease Information Management System, an Internet-based solution for monitoring and managing communicable and infectious disease information; and Clinical-Care Globalization, a clinical-care globalization technology. Its products also include MC-Telehealth, a mobile clinic with telehealth system technology; Kallo Integrated Delivery System (KIDS), a technology and process framework that defines and describes the component parts of the various products and services; and KIDS Global Tele-Health Ecosystems, a Tele-health Program that encompasses various technologies and administrative processes needed to deliver virtual medical care, health promotion/prevention, and other patient education to KIDS patients. The company was formerly known as Diamond Technologies Inc. The company was incorporated in 2006 and is headquartered in Toronto, Canada.
www.kalloinc.ca2
Full Time Employees
December 31
Fiscal Year Ends
Sector
Industry
Recent News: KALO
Performance Overview: KALO
Trailing total returns as of 5/15/2024, which may include dividends or other distributions. Benchmark is .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: KALO
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: KALO
Valuation Measures
Market Cap
1.91M
Enterprise Value
3.73M
Trailing P/E
0.05
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
--
Price/Book (mrq)
--
Enterprise Value/Revenue
--
Enterprise Value/EBITDA
--
Financial Highlights
Profitability and Income Statement
Profit Margin
0.00%
Return on Assets (ttm)
-6,146.04%
Return on Equity (ttm)
--
Revenue (ttm)
--
Net Income Avi to Common (ttm)
-706.46k
Diluted EPS (ttm)
0.0100
Balance Sheet and Cash Flow
Total Cash (mrq)
767
Total Debt/Equity (mrq)
--
Levered Free Cash Flow (ttm)
-44.36M
Research Analysis: KALO
Company Insights: KALO
KALO does not have Company Insights